Comparative efficacy and safety of vedolizumab and antitumor necrosis factor alfa in patients with inflammatory bowel diseases: A meta‑analysis

This meta-analysis directly compares the efficacy and safety of vedolizumab and tumor necrosis factor-α (TNF-α) inhibitors for patients with inflammatory bowel disease (IBD), contrary to the previous one which provided an indirect comparison. In this meta-analysis, only the studies that directly com...

Full description

Bibliographic Details

Published in:	Acta Pharmaceutica
Main Authors:	Li Yafang, Ding Jin, Lu Chong, Hong Yiping, Wang Qunying
Format:	Article
Language:	English
Published:	Sciendo 2025-03-01
Subjects:	vedolizumab tnf-α inhibitors inflammatory bowel disease ulcerative colitis
Online Access:	https://doi.org/10.2478/acph-2025-0004